References
- Stalder J. F. Hydratation cutanée et atopie. Ann Dermatol Venereol 2002; 129: 147–51
- Cambazard F. Traitements de la dermatite atopique. La dermatite atopique, B Crickx, M Lamirand, J. F Nicolas. John Libbey Eurotext, Paris 2000; 97–106
- Lucky A. W., Leach A. D., Laskarzewski P., Wenck H. Use of an emollient as a steroid‐sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol 1997; 14: 321–4
- Hoare C., Li Wan Po A., Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4: 1–191
- Charman C., Chambers C., Williams H. Measuring atopic dermatitis severity in randomized controlled trials: what exactly are we measuring?. J Invest Dermatol 2003; 48: 553–63
- Severity scoring of atopic dermatitis: the Scorad index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23–31
- Lewis‐Jones M. S., Finlay A. Y. Children's dermatology life quality index: initial validation and practical use. Br J Dermatol 1995; 133: 942–9
- Holden C., English J., Hoare C., Jordan A., Kownacki S., Turnbull R., et al. Advised best practice for the use of emollients in eczema and other dry skin conditions. J Dermatol Treat 2002; 13: 103–6
- Guillet G. L'émollient et la peau atopique: objectifs et impératifs sur une peau sèche. Nouv Dermatol 1999; 18: 277–80
- Giordano‐Labadie F., Rancé F., Pellegrin F., Bazex J., Dutau G., Scharze H. P. Frequency of contact allergy in children with atopic dermatitis: results of a prospective study of 137 cases. Contact Dermatitis 1999; 40: 192–5
- Kiebert G., Sorensen S. V., Revicki D., Fagan S. C., Doyle J. J., Cohen J., et al. Atopic dermatitis is associated with a decrement in health‐related quality of life. Int J Dermatol 2002; 41: 151–8
- Grob J. J., Richard M. A. Instruments génériques et spécifiques pour la mesure de QdV en dermatologie. Ann Dermatol Venereol 2000; 127: 2S9–2S12